USPTO serial 78974607
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
LISLE, IL
SEATTLE, WA
SEATTLE, WA
Seattle, WA
Seattle, WA
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software for application and database integration in the area of drug information and pharmaceutical formulary management; Computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information in the area of drug information and pharmaceutical formulary management; Computer software for controlling and managing access server applications in the area of drug information and pharmaceutical formulary management; Computer software for providing an on-line database in the area of drug information and pharmaceutical formulary management; Computer software in the area of drug information and pharmaceutical formulary management for developing pharmacy spending policies including database management, use as a spreadsheet, creating word processing documents containing formularies and a variety of other exchange formats to enable the sharing of such formulary information among interested parties; Downloadable electronic publications in the nature of presentations, demonstrations, white papers, brochures, training materials and courseware in the area of drug information, pharmaceutical formularies and pharmaceutical formulary management | SECTION 8 - CANCELLED | — |
| 016 | Publications, namely, training manuals, instructor guides, and self-paced workbooks, in the area of drug information, pharmaceutical formularies and pharmaceutical formulary management | SECTION 8 - CANCELLED | — |
| 035 | Pharmaceutical cost management services and drug utilization review services in the nature of pharmaceutical formulary management, namely, the establishment of exclusionary and inclusionary drug lists, the allocation of specific drugs to a reimbursement "tier," the detailing of specific expense reimbursement policies including, but not limited to, quantity limits, gender limit, step therapies, and the electronic distribution of business information, namely, pharmaceutical formularies, to interested parties; Providing business information in the area of pharmaceutical formulary management; providing business information in the field of formulary management via an online subscriber interactive database, providing an on-line computer database in the field of pharmaceutical cost management services and drug utilization review services, namely, pharmaceutical formulary management | SECTION 8 - CANCELLED | — |
| 036 | Providing physicians, pharmacists, medical group administrators, medical plan administrators, medical providers and health providers with insurance information in the area of pharmaceuticals; providing pharmaceutical insurance benefits information via an online subscriber interactive database | SECTION 8 - CANCELLED | — |
| 041 | Providing non-downloadable on-line publications in the nature of presentations, demonstrations, white papers, brochures, training materials, and courseware in the field of pharmaceuticals | SECTION 8 - CANCELLED | — |
| 042 | Providing on-line non-downloadable software for use in database management, for exporting as a spreadsheet, word processing document or other exchange format, in the fields of pharmaceutical formulary management and drug information; document data transfer from one computer format to another, namely, the translation of formularies to a variety of exchange formats | SECTION 8 - CANCELLED | — |
| 044 | Providing information in the area of pharmaceuticals; providing pharmaceutical advice via an online subscriber interactive database; providing an on-line computer database in the field of drug information; providing pharmaceutical advice | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 19, 2019 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Dec 16, 2017 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Nov 5, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 5, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 7, 2015 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jan 7, 2015 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jan 5, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 15, 2014 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Mar 26, 2014 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 22, 2010 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 22, 2010 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 7, 2009 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Dec 16, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 12, 2008 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Nov 10, 2008 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 10, 2008 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 10, 2008 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 8, 2008 | IUAF | USE AMENDMENT FILED | — |
| Oct 8, 2008 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 8, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 30, 2008 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jan 15, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 26, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 10, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 7, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 4, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 4, 2007 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 4, 2007 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 4, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 14, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 12, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 12, 2007 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 11, 2007 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 11, 2007 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 19, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 19, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 19, 2007 | ALIE | ASSIGNED TO LIE | — |
| Mar 15, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2007 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 21, 2007 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 6, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 20, 2006 | NWAP | NEW APPLICATION ENTERED | — |